This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfaller, M. A.
Right arrow Articles by Rex, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfaller, M. A.
Right arrow Articles by Rex, J. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Jul 1996, 1691-1693, Vol 34, No. 7
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates

MA Pfaller, SA Messer, A Bolmstrom, FC Odds and JH Rex
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA.

A multicenter study was performed to establish the interlaboratory reproducibility of Etest, to provide an additional comparison of Etest MICs with reference broth macrodilution MICs, and to develop some tentative quality control (QC) guidelines for using Etest for antifungal susceptibility testing of Candida spp. Two QC strains, Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258, were tested by Etest against amphotericin B, fluconazole, flucytosine, itraconazole, and ketoconazole in each of four laboratories. The QC strains were tested 20 times each against the five antifungal agents by using a common lot of RPMI agar. A total of 80 MICs per drug per strain were generated during the study. Overall, 98 to 100% of the MICs fell within a 3 log2 dilution range for the respective yeast-antifungal agent combinations. The level of agreement of Etest MICs with broth macrodilution MICs was 86 to 100% with amphotericin B (C. krusei and C. parapsilosis), itraconazole (C. krusei and C. parapsilosis), flucytosine (C. parapsilosis), and fluconazole (C. parapsilosis). A lower level of agreement was observed with ketoconazole (C. krusei and C. parapsilosis). Although all participants reported identical Etest MICs, the MICs of flucytosine and fluconazole when tested against C. krusei fell well above the upper limits of the reference range for this strain. The tentative QC limits for the two QC strains and five antifungal agents when tested by the Etest methodology are the same as the QC limits when tested by the reference broth macrodilution method for amphotericin B and C. krusei, itraconazole and C. krusei, flucytosine and C. parapsilosis, fluconazole and C. parapsilosis, and itraconazole and C. parapsilosis. The Etest QC ranges are 1 dilution broader (4-dilution range) than the reference macrodilution method QC ranges for ketoconazole and C. krusei, amphotericin B and C. parapsilosis, and ketoconazole and C. parapsilosis.


This article has been cited by other articles:

  • Oliver, B. G., Silver, P. M., Marie, C., Hoot, S. J., Leyde, S. E., White, T. C. (2008). Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi. Microbiology 154: 960-970 [Abstract] [Full Text]  
  • Li, Y., Sun, S., Guo, Q., Ma, L., Shi, C., Su, L., Li, H. (2008). In vitro interaction between azoles and cyclosporin A against clinical isolates of Candida albicans determined by the chequerboard method and time-kill curves. J Antimicrob Chemother 61: 577-585 [Abstract] [Full Text]  
  • Sar, B., Boy, S., Keo, C., Ngeth, C. C., Prak, N., Vann, M., Monchy, D., Sarthou, J. L. (2006). In Vitro Antifungal-Drug Susceptibilities of Mycelial and Yeast Forms of Penicillium marneffei Isolates in Cambodia. J. Clin. Microbiol. 44: 4208-4210 [Abstract] [Full Text]  
  • Chaturvedi, V., Ramani, R., Pfaller, M. A. (2004). Collaborative Study of the NCCLS and Flow Cytometry Methods for Antifungal Susceptibility Testing of Candida albicans. J. Clin. Microbiol. 42: 2249-2251 [Abstract] [Full Text]  
  • Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Bouman, B. A., Verweij, P. E. (2002). Comparison of the Etest and the Sensititre Colorimetric Methods with the NCCLS Proposed Standard for Antifungal Susceptibility Testing of Aspergillus Species. J. Clin. Microbiol. 40: 2876-2885 [Abstract] [Full Text]  
  • Liu, Y., Tortora, G., Ryan, M. E., Lee, H.-M., Golub, L. M. (2002). Potato Dextrose Agar Antifungal Susceptibility Testing for Yeasts and Molds: Evaluation of Phosphate Effect on Antifungal Activity of CMT-3. Antimicrob. Agents Chemother. 46: 1455-1461 [Abstract] [Full Text]  
  • Lewis, R. E., Diekema, D. J., Messer, S. A., Pfaller, M. A., Klepser, M. E. (2002). Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother 49: 345-351 [Abstract] [Full Text]  
  • Rex, J. H., Pfaller, M. A., Walsh, T. J., Chaturvedi, V., Espinel-Ingroff, A., Ghannoum, M. A., Gosey, L. L., Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Warnock, D. W. (2001). Antifungal Susceptibility Testing: Practical Aspects and Current Challenges. Clin. Microbiol. Rev. 14: 643-658 [Abstract] [Full Text]  
  • Arendrup, M., Lundgren, B., Jensen, I. M., Hansen, B. S., Frimodt-Moller, N. (2001). Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates. J Antimicrob Chemother 47: 521-526 [Abstract] [Full Text]  
  • Pfaller, M. A., Messer, S. A., Mills, K., Bolmström, A. (2000). In Vitro Susceptibility Testing of Filamentous Fungi: Comparison of Etest and Reference Microdilution Methods for Determining Itraconazole MICs. J. Clin. Microbiol. 38: 3359-3361 [Abstract] [Full Text]  
  • Clancy, C. J., Nguyen, M. H. (1999). Correlation between In Vitro Susceptibility Determined by E Test and Response to Therapy with Amphotericin B: Results from a Multicenter Prospective Study of Candidemia. Antimicrob. Agents Chemother. 43: 1289-1290 [Abstract] [Full Text]  
  • Martin-Mazuelos, E., Gutierrez, M. J., Aller, A. I., Bernal, S., Martinez, M. A., Montero, O., Quindos, G. (1999). A comparative evaluation of Etest and broth microdilution methods for fluconazole and itraconazole susceptibility testing of Candida spp.. J Antimicrob Chemother 43: 477-481 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Pfaller, M., Messer, S. A., Knapp, C. C., Killian, S., Norris, H. A., Ghannoum, M. A. (1999). Multicenter Comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A Reference Method for Testing Clinical Isolates of Common and Emerging Candida spp., Cryptococcus spp., and Other Yeasts and Yeast-Like Organisms. J. Clin. Microbiol. 37: 591-595 [Abstract] [Full Text]  
  • Pfaller, M. A., Messer, S. A., Karlsson, A., Bolmström, A. (1998). Evaluation of the Etest Method for Determining Fluconazole Susceptibilities of 402 Clinical Yeast Isolates by Using Three Different Agar Media. J. Clin. Microbiol. 36: 2586-2589 [Abstract] [Full Text]